Assessing a Therapy’s Potential Use and Adoption in Treatment Resistant Depression
To support a mid-stage clinical development program, a top-5 pharmaceutical company engaged Shift Health to obtain an understanding of physicians’ decision-making process with alternative therapies.
Shift Health conducted consultations with physicians across the US to understand patient profiles, protocols for administering alternative therapies, adherence, outcomes and longer-term care practices. We distilled these findings and created a ‘real-world monograph’ or target product profile (TPP) for the use of alternative therapy for treatment-resistant depression.
The insights Shift Health generated supported development efforts by enabling the client to stratify patient populations for greatest therapeutic benefits and optimize the development of future protocols for clinical use of their product.